ARCHIVES

House Passes 2.8 Percent Increase For NCI

This article is from The Cancer Letter archive.

Vol. 35 No. 45 | December 11, 2009

Download PDF Visit The Full Archive

Related Articles

Beth Israel Suspends Enrollment In Trials Following An Audit

October 22, 2010

Improved NCI Relations With FDA Cited As Model For Government Accord, Lasagna Committee Says

April 20, 1990

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005

Funding opportunities listed.

July 30, 2004

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007